?
1
MO378: The Importance of Community Pharmacy in Chronic Kidn..:
Cámara Ramos, Iker ; Escribá Martí, Gema ; Escudero Quesada, Veronica..
Nephrology Dialysis Transplantation. 37 (2022) Supplement_3 - p. , 2022
Nephrology Dialysis Transplantation. 37 (2022) Supplement_3 - p. , 2022
?
2
Pharmaceutical care program for patients with chronic kidne..:
Escribá-Martí, Gema ; Cámara-Ramos, Iker ; Climent-Catalá, María Teresa...
PLOS ONE. 17 (2022) 12 - p. e0278648 , 2022
PLOS ONE. 17 (2022) 12 - p. e0278648 , 2022
?
3
Validación del medidor de creatinina sanguínea Nova StatSen..:
José Espejo Guerrero ; Linda McGouh ; Íker Cámara Ramos..
https://www.farmaceuticoscomunitarios.org/es/journal-article/validacion-del-medidor-creatinina-sanguinea-nova-statsensor-xpress-r-una-farmacia. , 2020
https://www.farmaceuticoscomunitarios.org/es/journal-article/validacion-del-medidor-creatinina-sanguinea-nova-statsensor-xpress-r-una-farmacia. , 2020
?
4
Detección de nefrotóxicos y ajuste de dosis en pacientes co..:
Escribá-Martí, Gema ; Cámara-Ramos, Iker ; Climent-Catalá, María Teresa..
Farmacéuticos Comunitarios, 2023, Vol. 15, Núm. 4 (2023). , 2023
Farmacéuticos Comunitarios, 2023, Vol. 15, Núm. 4 (2023). , 2023
?
5
S4 File -:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/journal_contribution/S4_File_-/21773482. , 2022
https://figshare.com/articles/journal_contribution/S4_File_-/21773482. , 2022
?
6
Patients and medications grouped according to CKD stage:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Patients_and_medications_grouped_according_to_CKD_stage_/21773491. , 2022
https://figshare.com/articles/dataset/Patients_and_medications_grouped_according_to_CKD_stage_/21773491. , 2022
?
7
Number of patients proposed for and withdrawn from any medi..:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Number_of_patients_proposed_for_and_withdrawn_from_any_medicine_/21773512. , 2022
https://figshare.com/articles/dataset/Number_of_patients_proposed_for_and_withdrawn_from_any_medicine_/21773512. , 2022
?
8
Detail of the medications with dose adjustment and the pati..:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Detail_of_the_medications_with_dose_adjustment_and_the_patients_who_used_them_/21773500. , 2022
https://figshare.com/articles/dataset/Detail_of_the_medications_with_dose_adjustment_and_the_patients_who_used_them_/21773500. , 2022
?
9
Medicines for which a change is requested and the outcome o..:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Medicines_for_which_a_change_is_requested_and_the_outcome_of_the_request_/21773494. , 2022
https://figshare.com/articles/dataset/Medicines_for_which_a_change_is_requested_and_the_outcome_of_the_request_/21773494. , 2022
?
10
Time, in minutes, dedicated by each pharmacy to patient car:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Time_in_minutes_dedicated_by_each_pharmacy_to_patient_care_/21773515. , 2022
https://figshare.com/articles/dataset/Time_in_minutes_dedicated_by_each_pharmacy_to_patient_care_/21773515. , 2022
?
11
Classification of CKD by categories according to glomerular..:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Classification_of_CKD_by_categories_according_to_glomerular_filtration_rate_/21773485. , 2022
https://figshare.com/articles/dataset/Classification_of_CKD_by_categories_according_to_glomerular_filtration_rate_/21773485. , 2022
?
12
Detail of the medications that were discontinued and the pa..:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Detail_of_the_medications_that_were_discontinued_and_the_patients_who_used_them_/21773503. , 2022
https://figshare.com/articles/dataset/Detail_of_the_medications_that_were_discontinued_and_the_patients_who_used_them_/21773503. , 2022
?
13
S1 File -:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/journal_contribution/S1_File_-/21773470. , 2022
https://figshare.com/articles/journal_contribution/S1_File_-/21773470. , 2022
?
14
Number of patients for whom dose adjustment is proposed and..:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Number_of_patients_for_whom_dose_adjustment_is_proposed_and_those_for_whom_it_is_adjusted_/21773509. , 2022
https://figshare.com/articles/dataset/Number_of_patients_for_whom_dose_adjustment_is_proposed_and_those_for_whom_it_is_adjusted_/21773509. , 2022
?
15
Proposed changes and results obtained:
Gema Escribá-Martí (14295463) ; Iker Cámara-Ramos (14295466) ; María Teresa Climent-Catalá (14008901)..
https://figshare.com/articles/dataset/Proposed_changes_and_results_obtained_/21773497. , 2022
https://figshare.com/articles/dataset/Proposed_changes_and_results_obtained_/21773497. , 2022